
Increasing clinical trial expertise at the RI-MUHC
The RI-MUHC ACT-CTU reports on the realization of its vision for 2024 to build a clinical trials community and strengthen trial capabilities at the RI-MUHC

RI-MUHC study uses AI to understand liver cancer
A new publication describes the use of ALiX, a unique AI model, to analyze data from liquid biopsy

Developing technology for fight against antimicrobial resistance
New treatment under development by researchers Karine Auclair and Andréanne Lupien could potentially treat intracellular infections without...

A clinical trial shows benefits of finding and treating undiagnosed asthma and COPD
This innovative Canadian study, published in the New England Journal of Medicine, marks a world first

Gestational diabetes in subsequent pregnancies significantly increases risk of type 2 diabetes
Recent study reveals that the risk of developing type 2 diabetes is increased in women who first get gestational...

Pediatric egg-induced anaphylaxis characteristics, outcomes described in new publication
A team led by Moshe Ben-Shoshan has recruited the largest known cohort of egg-related anaphylaxis patients...

New findings illustrate pathway for screening high-risk individuals for pancreatic cancer
An international collaboration of scientists and healthcare professionals is developing a promising surveillance...

$10.6M grant supports innovative autism project
McGill Translational Platform in Autism Research will help uncover the disorders’ neural foundations

Beyond accessibility
How the Jooay App helps families find inclusive play opportunities for children with disabilities and connects families to their communities

Psychologist Tina Montreuil is making a difference
RI-MUHC researcher invited to provide expert testimony to the House of Commons regarding her project, the Montreal Antenatal Well-Being Study...